Chinese Biopharmaceutical Association-Usa Inc is located in Potomac, MD. The organization was established in 2008. According to its NTEE Classification (H92) the organization is classified as: Biomedicine & Bioengineering Research, under the broad grouping of Medical Research and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Chinese Biopharmaceutical Association-Usa Inc is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2021, Chinese Biopharmaceutical Association-Usa Inc generated $140.0k in total revenue. This represents relatively stable growth, over the past 7 years the organization has increased revenue by an average of 9.4% each year. All expenses for the organization totaled $31.3k during the year ending 12/2021. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2021
Describe the Organization's Mission:
Part 3 - Line 1
TO FACILIATE COLLABORATION AMONG BIOMEDICALPHARMACEUTICAL SCIENTISTS ENGINEERS AND OTHER RELATED PROFESSIONALS AND TO SERVE AS A BRIDGE
Describe the Organization's Program Activity:
Part 3 - Line 4a
HOLD CONFERENCES, MEETINGS, WORKSHOPS, AND ACTIVITIES TO FACILITATE COLLABORATION AMONG SCIENTISTS, ENGINEERS AND OTHER RETLATED PROFESSIONALS IN BIOPHARMACEUTICAL FIELD.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Ping Chen Director | Trustee | 1 | $0 |
Edward Wang Director | Trustee | 1 | $0 |
Richard Y Zhao Director | Trustee | 1 | $0 |
Shoupeng Lai Director | Trustee | 1 | $0 |
Xiaobin Lu Director | Trustee | 1 | $0 |
Xu-Rong Jiang Director | Trustee | 1 | $0 |
Statement of Revenue | |
---|---|
Federated campaigns | $0 |
Membership dues | $0 |
Fundraising events | $0 |
Related organizations | $0 |
Government grants | $0 |
All other contributions, gifts, grants, and similar amounts not included above | $139,662 |
Noncash contributions included in lines 1a–1f | $0 |
Total Revenue from Contributions, Gifts, Grants & Similar | $139,662 |
Total Program Service Revenue | $0 |
Investment income | $364 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $0 |
Net Rental Income | $0 |
Net Gain/Loss on Asset Sales | $0 |
Net Income from Fundraising Events | $0 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $140,026 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $0 |
Grants and other assistance to domestic individuals. | $0 |
Grants and other assistance to Foreign Orgs/Individuals | $0 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $0 |
Compensation of current officers, directors, key employees. | $0 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $0 |
Pension plan accruals and contributions | $0 |
Other employee benefits | $0 |
Payroll taxes | $0 |
Fees for services: Management | $0 |
Fees for services: Legal | $0 |
Fees for services: Accounting | $800 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $0 |
Fees for services: Other | $0 |
Advertising and promotion | $1,019 |
Office expenses | $1,015 |
Information technology | $3,478 |
Royalties | $0 |
Occupancy | $0 |
Travel | $2,067 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $14,331 |
Interest | $0 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $0 |
Insurance | $0 |
All other expenses | $3,902 |
Total functional expenses | $31,264 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $713,657 |
Savings and temporary cash investments | $0 |
Pledges and grants receivable | $0 |
Accounts receivable, net | $0 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $0 |
Net Land, buildings, and equipment | $0 |
Investments—publicly traded securities | $0 |
Investments—other securities | $0 |
Investments—program-related | $0 |
Intangible assets | $0 |
Other assets | $0 |
Total assets | $713,657 |
Accounts payable and accrued expenses | $0 |
Grants payable | $0 |
Deferred revenue | $0 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $0 |
Unsecured mortgages and notes payable | $0 |
Other liabilities | $0 |
Total liabilities | $0 |
Net assets without donor restrictions | $0 |
Net assets with donor restrictions | $0 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $713,657 |
Total liabilities and net assets/fund balances | $713,657 |
Over the last fiscal year, we have identified 1 grants that Chinese Biopharmaceutical Association-Usa Inc has recieved totaling $85.
Awarding Organization | Amount |
---|---|
Amazonsmile Foundation Seattle, WA PURPOSE: GENERAL SUPPORT | $85 |
Organization Name | Assets | Revenue |
---|---|---|
Global Genomics And Bioinformatics Research Institute Fairfax, VA | $41,758,166 | $3,961,424 |
Institute For Gene And Cell Therapies Washington, DC | $285,097 | $1,200,000 |
Foundation For Biomedical Research Washington, DC | $19,886,643 | $1,890,553 |
Gardp North America Inc Philadelphia, PA | $898,589 | $1,104,000 |
Center For Genetics Nutrition And Health Inc Washington, DC | $146,885 | $87,799 |
International Society For Hyaluronan Sciences Wilmington, DE | $274,267 | $88,672 |
Chinese Biopharmaceutical Association-Usa Inc Potomac, MD | $713,657 | $140,026 |